Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goli Samimi

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patientsGoli Samimi, Nissi M Varki, Sharon Wilczynski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cellsKuniyuki Katano, Roohangiz Safaei, Goli Samimi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2017
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survivalSarah M Temkin, Eric A Miller, Goli Samimi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 3, 2022
Report from an NCI Roundtable: Cancer Prevention in Primary CareGoli Samimi, Jasmine Douglas, Brandy M Heckman-Stoddard, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2003
Cross-resistance to cisplatin in cells with acquired resistance to copperRoohangiz Safaei, Kuniyuki Katano, Goli Samimi, et al.
Molecular Pharmacology|July 2, 2004
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cellsAlison K Holzer, Goli Samimi, Kuniyuki Katano, et al.
American Journal of Obstetrics and Gynecology|August 25, 2020
Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-sponsored workshop: gynecology and women's health-benign conditions and cancerGoli Samimi, Neeraja Sathyamoorthy, Candace M Tingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cellsGoli Samimi, Roohangiz Safaei, Kuniyuki Katano, et al.
Cytometry|January 5, 2002
Using mRNA expression profiling to determine anticancer drug efficacyGerrit Los, Fei Yang, Goli Samimi, et al.
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patientsGoli Samimi, Nissi M Varki, Sharon Wilczynski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cellsKuniyuki Katano, Roohangiz Safaei, Goli Samimi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2017
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survivalSarah M Temkin, Eric A Miller, Goli Samimi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 3, 2022
Report from an NCI Roundtable: Cancer Prevention in Primary CareGoli Samimi, Jasmine Douglas, Brandy M Heckman-Stoddard, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2003
Cross-resistance to cisplatin in cells with acquired resistance to copperRoohangiz Safaei, Kuniyuki Katano, Goli Samimi, et al.
Molecular Pharmacology|July 2, 2004
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cellsAlison K Holzer, Goli Samimi, Kuniyuki Katano, et al.
American Journal of Obstetrics and Gynecology|August 25, 2020
Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-sponsored workshop: gynecology and women's health-benign conditions and cancerGoli Samimi, Neeraja Sathyamoorthy, Candace M Tingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cellsGoli Samimi, Roohangiz Safaei, Kuniyuki Katano, et al.
Cytometry|January 5, 2002
Using mRNA expression profiling to determine anticancer drug efficacyGerrit Los, Fei Yang, Goli Samimi, et al.
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.
Pageof 8